We are live on ! Find out more
NI

Nextech Invest Portfolio holdings

AUM $1.42B
1-Year Est. Return 304.47%
This Fund
S&P 500
This Quarter Est. Return
-20.47%
1 Year Est. Return
+304.47%
3 Year Est. Return
+631.11%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$350M
AUM Growth
-$29.3M
Cap. Flow
+$63.9M
Cap. Flow %
18.25%
Top 10 Hldgs %
90.47%
Holding
14
New
3
Increased
1
Reduced
–
Closed
–

Top Buys

Rank Stock Value
1
RVMD icon
Revolution Medicines
RVMD
+$21.1M
2
MRTX
Mirati Therapeutics, Inc. Common Stock
MRTX
+$17.7M
3
BPMC
Blueprint Medicines
BPMC
+$13.5M
4
RLAY icon
Relay Therapeutics
RLAY
+$11.5M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
RVMD icon
1
Revolution Medicines
RVMD
$39.1B
$100M 28.69%
3,939,529
+971,315
+33% +$21.1M
EQRX
2
DELISTED
EQRx, Inc. Common Stock
EQRX
$54.1M 15.45%
13,104,424
– –
KNTE
3
DELISTED
Kinnate Biopharma Inc. Common Stock
KNTE
$33.9M 9.67%
3,008,243
– –
PMVP icon
4
PMV Pharmaceuticals
PMVP
$57.1M
$28.9M 8.24%
1,385,807
– –
TYRA icon
5
Tyra Biosciences
TYRA
$1.89B
$26.9M 7.69%
2,518,582
– –
ARVN icon
6
Arvinas
ARVN
$534M
$19.3M 5.52%
287,251
– –
MRTX
7
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
$14.2M 4.07%
+173,300
New +$17.7M
RLAY icon
8
Relay Therapeutics
RLAY
$4.13B
$14.2M 4.06%
+475,485
New +$11.5M
CGEM icon
9
Cullinan Oncology
CGEM
$1.07B
$12.8M 3.65%
1,221,145
– –
BPMC
10
DELISTED
Blueprint Medicines
BPMC
$12M 3.43%
+188,228
New +$13.5M
KRON
11
DELISTED
Kronos Bio
KRON
$10.5M 3%
1,451,537
– –
CCCC icon
12
C4 Therapeutics
CCCC
$401M
$9.12M 2.6%
375,857
– –
THRX
13
DELISTED
Theseus Pharmaceuticals, Inc. Common Stock
THRX
$7.05M 2.01%
611,310
– –
SPRY icon
14
ARS Pharmaceuticals
SPRY
$575M
$6.7M 1.91%
1,910,029
– –

Similar funds

BC
Broadwood Capital New York $1.42B AUM 34.72% 1-Year Est. Return
IHG
Insight Holdings Group New York $1.42B AUM 41.03% 1-Year Est. Return
PTC
Philadelphia Trust Company Philadelphia, Pennsylvania $1.42B AUM 43.77% 1-Year Est. Return
PPC
Park Presidio Capital San Francisco, California $1.43B AUM 21.33% 1-Year Est. Return
KCMH
Kontiki Capital Management (HK) Hong Kong $1.43B AUM 9.81% 1-Year Est. Return
APCM
Alaska Permanent Capital Management Anchorage, Alaska $1.43B AUM 13.12% 1-Year Est. Return
CBA
Coastal Bridge Advisors Westport, Connecticut $1.41B AUM 24.15% 1-Year Est. Return
KC
Kryger Capital London, United Kingdom $1.41B AUM 86.31% 1-Year Est. Return

Nextech Invest's Q1 2022 Portfolio in Review

As of Q1 2022, Nextech Invest held 14 positions worth $350M, down 7.7% from $380M the previous quarter. Its ten largest holdings account for 90% of the portfolio.

Nextech Invest deployed $63.9M of net new capital in Q1 2022, opening 3 new positions and adding to 1 existing holding. Its largest new stake was Mirati Therapeutics, Inc. Common Stock: 173,300 shares worth $14.2M.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • Nextech Invest's largest Q1 2022 buy was Mirati Therapeutics, Inc. Common Stock: 173,300 shares worth $14.2M.
  • Nextech Invest added most to Revolution Medicines in Q1 2022, an estimated $21.1M increase.
  • Nextech Invest's ten largest holdings make up 90% of its $350M portfolio in Q1 2022.
  • Nextech Invest opened 3 new positions and closed 0 in Q1 2022.
  • Nextech Invest's portfolio value fell 7.7% quarter-over-quarter to $350M.

Based on Nextech Invest's 13F filing for Q1 2022, filed 16 May 2022.